PlainRecalls
FDA Drug Low Class III Terminated

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Reported: March 20, 2019 Initiated: March 1, 2019 #D-0990-2019

Product Description

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Reason for Recall

Failed Dissolution Specifications

Details

Recalling Firm
AVKARE Inc.
Units Affected
a) 2947 and b) 3379
Distribution
Nationwide.
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478. Recalled by AVKARE Inc.. Units affected: a) 2947 and b) 3379.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on March 20, 2019. Severity: Low. Recall number: D-0990-2019.